טוען...

A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance

OBJECTIVE: Real-life safety and efficacy of sorafenib in advanced renal cell carcinoma in a nationwide patient population were evaluated by post-marketing all-patient surveillance. METHODS: All patients with unresectable or metastatic renal cell carcinoma in Japan who started sorafenib therapy from...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Jpn J Clin Oncol
Main Authors: Akaza, Hideyuki, Oya, Mototsugu, Iijima, Masafumi, Hyodo, Ichinosuke, Gemma, Akihiko, Itoh, Hiroshi, Adachi, Masatoshi, Okayama, Yutaka, Sunaya, Toshiyuki, Inuyama, Lyo
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2015
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4598240/
https://ncbi.nlm.nih.gov/pubmed/26206897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyv099
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!